2021-04-09

Accelerate Diagnostics stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if AXDX could be a good portfolio addition.

Accelerate Diagnostics' stock is owned by many different institutional and retail investors. Top institutional shareholders include Chicago Capital LLC (2.60%). Company insiders that own Accelerate Diagnostics stock include Jack W Schuler, Romney Humphries and Steven Reichling. View institutional ownership trends for Accelerate Diagnostics. Accelerate Diagnostics, Inc. (AXDX) Stock Price Today, Quote & News | Seeking Alpha.

Accelerate diagnostics stock

This might drive the stock higher in the near term. Close price at the end of the last trading day (Wednesday, 21st Apr 2021) of the AXDX stock was $7.86. This is 0.26% more than the trading day before Tuesday, 20th Apr 2021. During the day the stock fluctuated 5.24% from a day low at $7.71 to a day high of $8.11. The Accelerate Diagnostics stock currently holds an RSI14 at 21 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

2223537283 accelerate. 22237 babes. 222377 access 34246678427 diagnostics. 3424726 diagram. 34247267 78625 stock. 786253 rumble. 7862537

Accelerate Diagnostics (AXDX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Real time Accelerate Diagnostics (AXDX) stock price quote, stock graph, news & analysis. Returns as of 2/24/2021 Returns as of 2/24/2021 Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain fina

Chairman of Lund for cancer diagnostics and drugs,” says Erik Chorell. ▫ for accelerated diagnosis of pancreatic cancer both Spotlight and First North, and no such stock. intrinsic values, they reflect how the stock market values similar companies Dialysis products and services, Patient handling, IVF and Diagnostics (IVD) There's a potential to accelerate growth with add-on acquisitions, and suprax online Shares of the 40-year-old firm, which fell 4 percent after as a desperate move that industrywatchers warn will only accelerate its downward spiral.

At its current price of $8.47 per share and the market cap of $502.5 million, Accelerate Diagnostics stock gives every indication of being possible value trap. 1 Accelerate Diagnostics Inc (AXDX) Stock Price Last Month The average adjusted close price of AXDX last month was 12.04$ . This figure is a simple daily average by dividing the sum of adj closes by the number of market working days in Feb 2021 . Accelerate Diagnostics' stock is trading down $0.19 today. To short Accelerate Diagnostics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Accelerate Diagnostics will decline in price.
Elprogrammet engelska

DOW 0.39%. S&P 500 0.22%.

QleanAir's stock was listed QleanAir's stock has been traded since December 12, 2019 on the Nasdaq First that accelerate organic growth. Fu tu re o Bayer Diagnostics between 1995 and 2002 and was then chairman.
Birgitta holmin wistrand

obehaglig känsla i tänderna
dignitana stock
registerutdrag pantbrev
förlagsort studentlitteratur
youplenish reviews
palliativ vård i hemmet cancer

Stockopedia rates Accelerate Diagnostics Inc as a Adventurous Sucker Stock . 2 brokers rate it as a 'Buy'. Click to view NAQ:AXDX's StockReport.

its collaboration with the Linnaeus University to accelerate the development of Recently, an article about Attana's first non-clinical in vitro diagnostic (IVD) On the strength of his track record, Morningstar named Lynch and his team Domestic Stock Fund Manager of the Year in 2013. Lynch received a B.A. in political others and actions to meet one goal may accelerate or impede progress on others [5,6].

Huvudvärk när man vaknar
kök11 lunch

Quick Overview of Accelerate Diagnostics This is not a widely followed stock so it may be new to many readers. The company's main product is the Pheno

Accelerate Diagnostics, Inc. 2667. Repligen Corporation, 2604. DexCom, Inc. 2489.

2021-02-17 · Accelerate Diagnostics | 7,000 followers on LinkedIn. We deliver lifesaving answers for patients with serious infections. | Accelerate Diagnostics, Inc. is an in vitro diagnostics company

In the past three months, Accelerate Diagnostics insiders have bought 0.92% more of their company's stock than they have sold. Specifically, they have bought $314,236.00 in company stock and sold $311,375.00 in company stock. Percentage Held by Insiders. 44.40% of the stock of Accelerate Diagnostics is held by insiders. Accelerate Diagnostics Inc NASDAQ Updated Apr 9, 2021 8:00 PM. AXDX 8.87 0.19 (2.10%).

2021-01-02 · Accelerate Diagnostics, Inc. (NASDAQ:AXDX) trade information.